Article preview from The RPM Report - September 2009
One of the Obama Administration’s first moves in managing the Medicare Part D benefit is straight out of the Bush Administration’s approach to the drug benefit: tweaking the rules to tamp down on the number of beneficiaries who will be randomly assigned to a new plan on Jan. 1. Stability is good for the program politically, but pharma companies will need to watch to see whether there is more hands-on management by the Medicare agency in the years ahead. Read on...
Article preview from The RPM Report - September 2009
Health care reform is agenda item number one for the Obama Administration, and the give-and-take of the legislative process understandably dominates the headlines in health policy.
But for pharmaceutical companies, there is one critical element of reform that the new administration can accomplish without an act of Congress: bringing a new set of priorities to the management of the Medicare Part D prescription drug program.
And, in one of its first moves to nudge the program into a slightly different direction, the Medicare agency decided to tweak the rules governing assignment of the low-income beneficiaries. Thanks to the change, fewer beneficiaries will be automatically enrolled in a new plan in 2010 than were in 2009.
Read the rest of this 1,509-word article now, simply follow this link and purchase it as PDF today. Or subscribe to The RPM Report today-- click here for details.
